SecSonar.com

Utah Medical Products, Inc. (UTMD)

Utah Medical Products, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Utah Medical Products, Inc. (UTMD) is a Medical - Instruments & Supplies company based in US with a market capitalization of $213.6M. Revenue declined 5.8% year-over-year and the company generated $14.3M in free cash flow. This page tracks UTMD's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 155 employees · IPO Mar 8, 1999

Valuation

Valuation & price

$63.34 · as of May 17, 2026 · -14.4% vs 52w high

18.2

P/E ratio

Latest-FY diluted EPS

1.79

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$73.97$63.88$53.80Jul 25Dec 25Jul 26Jul 7, 25$57.19Jul 9, 25$57.26Jul 11, 25$56.43Jul 15, 25$55.93Jul 17, 25$56.02Jul 21, 25$55.55Jul 23, 25$58.18Jul 25, 25$58.55Jul 29, 25$56.42Jul 31, 25$55.60Aug 4, 25$56.78Aug 6, 25$56.25Aug 11, 25$56.25Aug 13, 25$59.40Aug 15, 25$55.48Aug 19, 25$58.39Aug 21, 25$57.49Aug 25, 25$60.34Aug 27, 25$61.12Aug 29, 25$62.21Sep 3, 25$61.06Sep 5, 25$63.40Sep 9, 25$62.80Sep 11, 25$62.54Sep 16, 25$62.50Sep 18, 25$63.44Sep 22, 25$63.27Sep 24, 25$62.87Sep 26, 25$62.81Sep 30, 25$62.97Oct 2, 25$63.87Oct 6, 25$62.72Oct 8, 25$63.43Oct 10, 25$61.33Oct 14, 25$60.15Oct 16, 25$60.08Oct 21, 25$60.45Oct 23, 25$60.45Oct 27, 25$59.23Oct 29, 25$57.02Oct 31, 25$58.10Nov 4, 25$58.25Nov 6, 25$57.88Nov 10, 25$57.28Nov 12, 25$56.20Nov 14, 25$55.38Nov 18, 25$54.63Nov 20, 25$53.80Nov 25, 25$55.93Nov 28, 25$56.35Dec 2, 25$54.88Dec 4, 25$55.99Dec 8, 25$55.52Dec 10, 25$56.44Dec 12, 25$58.10Dec 16, 25$58.43Dec 18, 25$57.39Dec 22, 25$56.61Dec 24, 25$56.29Dec 29, 25$57.15Jan 2, 26$56.50Jan 6, 26$57.24Jan 8, 26$58.73Jan 12, 26$59.88Jan 14, 26$58.92Jan 16, 26$61.15Jan 21, 26$62.77Jan 23, 26$61.25Jan 27, 26$62.87Jan 29, 26$61.65Feb 2, 26$61.76Feb 4, 26$61.88Feb 9, 26$62.39Feb 11, 26$64.20Feb 13, 26$64.10Feb 18, 26$64.61Feb 20, 26$67.82Feb 24, 26$66.72Feb 26, 26$66.56Mar 2, 26$67.09Mar 4, 26$66.20Mar 6, 26$65.12Mar 10, 26$63.78Mar 12, 26$62.64Mar 17, 26$64.05Mar 19, 26$64.00Mar 23, 26$65.13Mar 25, 26$63.71Mar 27, 26$61.54Mar 31, 26$61.99Apr 2, 26$63.12Apr 7, 26$63.47Apr 9, 26$64.86Apr 13, 26$67.15Apr 15, 26$68.80Apr 17, 26$70.65Apr 22, 26$69.63Apr 24, 26$67.17Apr 28, 26$66.61Apr 30, 26$65.42May 4, 26$64.65May 6, 26$64.41May 8, 26$65.35May 12, 26$63.82May 14, 26$63.70May 18, 26$64.00May 20, 26$64.17May 22, 26$64.51May 28, 26$66.27Jun 1, 26$66.18Jun 3, 26$65.53Jun 5, 26$67.65Jun 9, 26$68.07Jun 11, 26$69.44Jun 15, 26$69.87Jun 17, 26$65.70Jun 22, 26$66.14Jun 24, 26$66.47Jun 26, 26$73.97Jul 2, 26$73.17
$53.8052-week range$73.97
Loading valuation history…

Fundamentals

Key fundamentals

$213.6M

Market cap

-5.8%

Revenue growth (YoY)

51.6%

Gross margin

$14.3M

Free cash flow (USD)

-$85.5M

Net debt

Net cash position

-5.5%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$39.3MFY 2017$41.4MFY 2018$42.0MFY 2019$46.9MFY 2020$42.2MFY 2021$49.1MFY 2022$52.3MFY 2023$50.2MFY 2024$40.9MFY 2025$38.5M
$39.3M$38.5M

Free cash flow by year

2016 → 2025

FY 2016$11.2MFY 2017$15.3MFY 2018$16.4MFY 2019$-4.5MFY 2020$19.3MFY 2021$20.7MFY 2022$20.3MFY 2023$21.6MFY 2024$14.6MFY 2025$14.3M
$11.2M$14.3M

Gross margin by year

2021 → 2025

FY 202163.0%FY 202261.6%FY 202359.8%FY 202459.0%FY 202551.6%
63.0%51.6%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 12, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Quarterly report10-Q FiledMay 12, 2026Filing
  • 8-K eventAnnual Meeting ResultsMay 4, 2026Filing
  • 8-K eventEarnings ReleaseApr 23, 2026Filing

Questions

Frequently asked questions

What is Utah Medical Products, Inc.'s market cap?

Utah Medical Products, Inc. (UTMD) has a market capitalization of $213.6M.

What is UTMD's P/E ratio?

UTMD trades at a price-to-earnings ratio of 18.2, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is UTMD's price-to-book (P/B) ratio?

UTMD trades at 1.79 times book value per share.

Are insiders buying UTMD stock?

SEC Form 4 filings show no open-market insider buys at Utah Medical Products, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Medical - Instruments & Supplies

SMTI

Sanara MedTech Inc.

$213.1M

PDEX

Pro-Dex, Inc.

$214.6M

STXS

Stereotaxis, Inc.

$196M

INFU

InfuSystem Holdings, Inc.

$190.7M

KRMD

KORU Medical Systems, Inc.

$188.8M

OSUR

OraSure Technologies, Inc.

$294.9M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.